News Releases

Un nouveau dosage permet aux hôpitaux d'améliorer de façon efficace la gestion des patients cardiaques BREA, Californie, 7 novembre 2017 /PRNewswire/ -- Beckman Coulter Diagnostics a annoncé...

La nueva prueba permite a los hospitales proporcionar una mejora en la gestión eficaz de los enfermos cardiacos BREA, California, 7 de noviembre de 2017 /PRNewswire/ -- Beckman Coulter...

Krankenhäuser können mit neuem Assay Effizienzverbesserungen im Herzpatientenmanagement erzielen BREA, Kalifornien, 7. November 2017 /PRNewswire/ -- Beckman Coulter Diagnostics gab heute...

New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, Calif. —(Nov. 7, 2017) — Beckman Coulter Diagnostics announced today that it has received CE...

Beckman Coulter Diagnostics is pleased to announce worldwide availability of the Access 2 immunoassay system with enhanced features. Built upon a 20-year legacy of reliable and efficient...

Beckman Coulter Diagnostics introduces its DxONE information management solutions, an integrated system of technologies and capabilities, designed to ease data access and usability. DxONE is...

Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry will present its global initiative, "Partnering Today for a Stronger Tomorrow," at the 69th American Association...

Beckman Coulter Diagnostics along with partner Diazyme Laboratories announces FDA clearance of a new procalcitonin (PCT) assay, an important tool for the management of bacterial infections and sepsis.

Organization also premieres a suite of new products designed to improve operational efficiency and drive clinical excellence. NYON, Switzerland—(June 12, 2017) — Today at the 22nd IFCC-EFLM...

Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis BREA, Calif. — (April 20, 2017) — Beckman Coulter Diagnostics announced a...